🇺🇸 Latanoprost ophthalmic solution 0.005% in United States

Latanoprost ophthalmic solution 0.005% (Latanoprost ophthalmic solution 0.005%) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Latanoprost ophthalmic solution 0.005% in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Latanoprost ophthalmic solution 0.005% approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Latanoprost ophthalmic solution 0.005% in United States?

Aerie Pharmaceuticals is the originator. The local marketing authorisation holder may differ — check the official source linked above.